Genome-wide association studies have revealed that common noncoding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT(2)) increase type 2 diabetes (T2D) risk(1,2). Although the strongest association signal was highly significant (P < 1 × 10(-20)), its contribution to T2D risk was modest (odds ratio (OR) of ∼1.10-1.15)(1-3). We performed large-scale exon resequencing in 7,632 Europeans, including 2,186 individuals with T2D, and identified 40 nonsynonymous variants, includ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
If you are the owner of this record, you can report an update to it here: Report update to this record